Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Journal of Clinical Hypertension (Greenwich, Conn.)|December 23, 2003
Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Vasilios Papademetriou, Linda B Piller, Charles E Ford, et al.
Heart Rhythm|June 22, 2011
Targeted nonviral gene-based inhibition of Gα(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillationGary L Aistrup, Ivan Cokic, Jason Ng, et al.
Contemporary Clinical Trials|January 20, 2016
Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adultsDiane R Gold, Augusto A Litonjua, Vincent J Carey, et al.
Contemporary Clinical Trials|October 12, 2011
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseJoann E Manson, Shari S Bassuk, I-Min Lee, et al.
JAMA Oncology|November 22, 2019
Effect of Supplementation With Marine ω-3 Fatty Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General Population: A Prespecified Ancillary Study of a Randomized Clinical TrialMingyang Song, I-Min Lee, JoAnn E Manson, et al.
Molecular Therapy. Methods & Clinical Development|March 3, 2025
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primatesMengping Liu, Erica Cook, Yanshan Dai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2020
No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized TrialMingyang Song, I-Min Lee, JoAnn E Manson, et al.
Cardiovascular Research|May 22, 2009
Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuationGary L Aistrup, Roger Villuendas, Jason Ng, et al.
Circulation. Heart Failure|March 5, 2021
In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart FailurePeter Gargalovic, Pancras Wong, Joelle Onorato, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 6, 2007
Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atriumRishi Arora, Joseph S Ulphani, Roger Villuendas, et al.
Pageof 37